IQVIA Biotech Thought Leadership

  1. Reducing Patient Burden: Considerations For Virtual Dermatology Trials 8/19/2021

    While it is not practical to think every dermatology trial can be 100% virtual, it is possible to customize and incorporate virtual aspects into these programs with a hybrid approach.

  2. The Emerging Pharmaco's Dilemma: Make A Deal…Or Not? 7/26/2021

    IQVIA Biotech analyzed the approaches of companies that launched products for the first time to understand their funding/commercialization strategies. This white paper presents the results of this analysis and discusses the implications for the three types of players involved.

  3. Virtual Approaches In Oncology Clinical Trials During COVID-19 And Onward 3/4/2021

    Patients living with cancer are among the most vulnerable during the pandemic, but sponsors and researchers understand oncology drug development must continue. This paper discusses how COVID-19 is driving change in the oncology trial landscape and how these insights may shape the future of post-pandemic clinical development.